Medical Data Vision Co., Ltd.

Tokyo Stock Exchange 3902.T

Medical Data Vision Co., Ltd. EBITDA for the year ending December 31, 2023: USD 13.27 M

Medical Data Vision Co., Ltd. EBITDA is USD 13.27 M for the year ending December 31, 2023, a -8.80% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Medical Data Vision Co., Ltd. EBITDA for the year ending December 31, 2022 was USD 14.55 M, a -3.05% change year over year.
Medical Data Vision Co., Ltd. EBITDA for the year ending December 31, 2021 was USD 15.00 M, a 25.51% change year over year.
Medical Data Vision Co., Ltd. EBITDA for the year ending December 31, 2020 was USD 11.95 M, a 54.92% change year over year.
Medical Data Vision Co., Ltd. EBITDA for the year ending December 31, 2019 was USD 7.72 M, a 74.46% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Tokyo Stock Exchange: 3902.T

Medical Data Vision Co., Ltd.

CEO	Mr. Hiroyuki Iwasaki
IPO Date	Dec. 16, 2014
Location	Japan
Headquarters	Sumitomo Fudosan Kanda Building
Employees	262
Sector	Health Care
Industries Medical Instruments Pharmaceuticals Research & Consulting

Description

Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company also offers medical data analysis, survey, and consulting services; management consulting services for medical institutions; and medical data services, as well as plans, designs, develops, and operates portal sites. It provides its services to pharmaceutical companies, medical device manufacturer, academia, research institution, and health insurance providers. The company was founded in 2003 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years